Speaker illustration

Doctor Alexander Stiby

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

Impact of ACLY on type 2 diabetes in UK Biobank: A Mendelian randomisation study

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacogenetics

Session: Highlights from the Young on cutting edge therapy for lowering lipids


Impact of history of vascular disease on lipoprotein(a) associations with cardiovascular outcomes: a Mendelian randomisation study in 283,658 UK Biobank participants

Event: ESC Congress 2019

Topic: Epidemiology

Session: How good/bad are we in treating lipids


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb